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Results. Mean age: 64.76 years (38–88). FIGO Stage: I (66.93%), II (17.53%), III (15.54%). T: < 2cm: 86.45%, > 2cm: 13.55%. Pathology:
endometrioid 74.61%, papillary 2.73%, serous 2.73%, papillary-serous 2.34%, clear-cell 3.13%. Grade (G): 41%G1, 39%G2, 19.67%G3;
myometrial invasion: 43.33%≥50%, 48.33%<50%, 8.33% not invasion. Treatment: (1) Surgery performed: 97.32% (88% abdominal,
11.96% vaginal, 54.28% lymph node dissection (32.24% pelvic, 20% pelvic and paraortic, paraortic only 2.04%). (2) External beam
irradiation (EBI) 62.07%, brachytherapy (BT) 52.90%. (3) Chemotherapy 11.51%, Hormonal therapy 6.3%. (4) Toxicity: 68.96% (G1-2),
7% (G3). Relapses: 9.96% locoregional recurrence and 10.34% at distance. Survival at 5 years: (1) 5-year OS in all stages was 80.1%
(84%, 90.3% and 64.5% for SI, SII and SIII, respectively). (2) 5-year DFS was 92.1% for all patients (93.5%, 97.5% and 79.8% for
SI, SII and SIII respectively. (3) 5-year LRFS was 93.7% for all patients (94.7%, 97.5% and 89.4% for SI, SII and SIII respectively).
Multivariate analysis: signiﬁcant prognostic factors for good outcome (OS andDFS)were lymphnode dissection, age<75, T≤2cm,
invasion≤50%, RT and BT.
Conclusions. Our results suggest that survival, RT toxicity and relapse were similar to the other reported series. Predictors of good
outcome were lymph node dissection, age, tumor size, myometrial invasion, RT and BT.
http://dx.doi.org/10.1016/j.rpor.2013.03.231
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Introduction. 10–30%of the patientswith locally advanced cervical cancer present para-aortic lymphnodemetastases at diagnosis.
Although PET-CT represents a signiﬁcant diagnosis advance, its sensitivity to detect para-aortic metastases ranges from 73–92%.
Therefore, surgical lymph node evaluation remains the gold standard in detecting para-aortic metastases.
Objectives. We present our experience in performing laparoscopic para-aortic lymph node dissection (LPL).
Material and methods. From November 2009 to January 2013, 32 patients with locally advanced cervical cancer (stages IB-IVB) were
included. As radiographic evaluation, pelvic MRI and CT were performed. Afterwards, LPL was performed. Ovarian transposition
in the same surgical procedure was offered to pre-menopausal patients. All patients received concurrent radiochemotherapy
and brachytherapy with radical intent after LPL.
Results. MRI detected pathologic pelvic lymphnodes in 43.75% of the patients (14 patients). CT scan showed pathologic para-aortic
lymph nodes in 15.6% (5 patients). The mean number of retrieved nodes was 14.84 (2–35). 4 patients (12.5%) had metastatic para-
aortic lymph nodes, while CT only had detected pathological lymph nodes in 1 patient. In the other 4 patients with abnormal CT,
lymph nodes were negative after surgery. With a median follow up of 24 months, only one patient (3%) presented side effects. It
was the ﬁrst LPL performed (patient HIV(+) with an abdominal abscess and peritonitis), and the complications had been solved
completely. No Grade III–IV side effects were reported. Radiochemotherapy was not delayed as a result of laparoscopy. General
and intestinal tolerance did not deterioratewith respect to previously recorded in patientswithout surgery orwith retroperitoneal
lymphadenectomy.
Conclusions. The laparoscopic para-aortic lymphadenectomy is an effective technique for staging in locally advanced cervical can-
cer, provides essential information for the design of radiotherapy volumes, with a very low morbidity rate, a short postoperative
recovery time, and without delaying treatment of the primary lesion.
http://dx.doi.org/10.1016/j.rpor.2013.03.232
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Introduction. CT and MRI sensibility for detecting para-aortic disease is 43% and 60%. PET-CT has higher sensibility (73–100%) and
speciﬁcity (97–99%). Surgical staging is the gold standard for detection, and the retroperitoneal laparoscopic approach the safer
technique. Although surgical approach seems appealing, the only randomized study to date comparing it to radiological staging
concluded it was detrimental. The objectives were to determine if the method used for para-aortic lymph node staging impacts
on overall survival in locally advanced cervical cancer (LACC).
Methods and materials. From June 1999 to October 2012, 273 LACC patients were sent to our department. After excluding patients
with: metastatic disease (8), pregnancy (5), synchronous tumors (4), and HIV (3); 253 patients were left for this study. FIGO stage
was: IB1 7, IB2 32, IIA 2, IIB 81, IIIA 1, IIIB 112, IVA 17 and IVB 1 (positive supraclavicular node treated with radical intent). The
staging method used was: CT and/or MRI (S1), PET-CT (S2) and surgical staging (S3) in 184, 46 and 23 patients respectively. Since
follow-up was shorter for S2, primary endpoint was established as overall survival (OS) at 3 years.
Results. At the time of the study, 172 patients were alive (15 with recurrent disease); 75 had died (8 without recurrence); and 6 were
lost to follow-up without evidence of disease. Actuarial 5 year OS was 70% (CI 95%: 63–76%). Median time from diagnostic biopsy
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to beginning chemoradiation was: 52.66 days for S1 (p25=34, p75=67); 58.77 days for S2 (p25=39, p75=76.5); and 83 days for S3
(p25=54, p75=111) (p<0.0001). 2 and 3 year OS was: 78 and 73% for S1; 79 and 79% for S2; and 70 and 61% for S3 (Log-Rank=0.4)
Conclusion. Delay in starting deﬁnitive therapy is longer after surgical staging. No statistically signiﬁcant differences were found
for OS by the staging method.
http://dx.doi.org/10.1016/j.rpor.2013.03.233
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Objectives. To analyze the results of the treatment in terms of disease-free survival, overall survival and cancer speciﬁc survival
in patients with endometrial cancer treated with surgery plus radiotherapy in our center.
Material and methods. Retrospective study of 369 patients with endometrial cancer treated with surgery plus radiation therapy
in our center from September 1992 to July 2008. Median age 63 years (range 32–86). 91% of patients had metrorrhagia as the
initial symptom and 93% underwent total hysterectomy plus bilateral adnexectomy with or without pelvic lymphadenectomy.
25 patients (7%) did not have surgery due to morbid obesity or medical contra indication. 80% of the patients were stage I–II and
16% stage III–IV. Adenocarcinoma endometriode (65.6%) was the most frequent histological type. 74% of the patients received
external-beam radiation therapy plus brachytherapy, 17% and 5% external radiation therapy or brachytherapy. 89% of the patients
were treatedwith 3Dconformal radiotherapy to thepelviswithorwithout a boost over parametriumandwithorwithout inclusion
of the periaortic nodes (median total dose of 50.24Gy (range 45–65)/2Gy/session/day). Kaplan–Meier curves have been used for
the statistical analysis of survival and Cox regression for the inﬂuence of prognostic factors in the results. Treatment-related
toxicity was assessed using the Radiation Therapy Oncology Group and the National Cancer Institute’s Common Terminology
Criteria for Adverse Events guidelines.
Results. With a median follow-up of 114 months (range 6–241), 14% of the patients had recurrence, 6% had distance metastases
and 2% local relapse. The 15 year disease-free survival, overall survival and cancer speciﬁc survival were 82%, 47% and 81%
respectively. The majority of the patients had initial and late grade 1–2 toxicity.
Conclusions. According to our long-term results the locoregional control in patients with endometrial cancer treated with surgery
plus radiotherapy is high, and the decrease in the overall survival rate was due to mortality in relation to age and comorbidities.
http://dx.doi.org/10.1016/j.rpor.2013.03.234
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Introduction. It’s necessary to establish an agreement about follow-up in cervix cancer. Most of the relapses appear in the ﬁrst two
years. It’s important to determine the local response as a basic prognostic factor and to plan a salvage surgery if it’s indicated.
The objectives were to establish a protocol in which MRI is used not only for staging but also for follow-up.
Material and methods. From September 2009 to January 2013, 31 cervix cancer patients (pt) were treated with radiochemotherapy
and brachytherapy with curative intent. A pelvic MRI, body CT and para-aortic lymphadenectomy were performed. Follow-up
visits were scheduled every three months during the ﬁrst two years, including physical and gynecological examination, cytology
(every six months) and chest X-ray (once a year). Also, two pelvic MRI were scheduled at 2 and 5 months.
Results. In 22 pts (73.3%), two pelvic MRI demonstrated that a complete radiological response was achieved. In this group of
patients, with a median follow-up of 21.1 months, 19 pts (86.3%) are no evidence of disease (NED), 2 pts have presented local
failure and 1 pt distant metastasis. In the remaining 8 pts (26.7%), the ﬁrst MRI showed a high probability of persistence of local
tumor. Of them, in 6 pts a PET-TAC was performed, with local tumor in 5 pts (one with distant metastasis also), and 1 pt without
any uptake. A salvage surgery could be planned in the 4 pts with local tumor in PET-TAC. The pathological examination showed
a pathological complete response in 2 pts and persistence of tumor in 2 pts.
Conclusions. Preliminary results of our follow-up protocol indicate that two pelvic MRI performed at 2 and 5 months after treat-
ment, could be enough for assessing local complete response in cervix cancer pts and for planning a local salvage treatment if
indicated
http://dx.doi.org/10.1016/j.rpor.2013.03.235
